Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor Malignancies, Cancer”

9,820 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,820 results

Early research (Phase 1)Study completedNCT03525925
What this trial is testing

Ibrutinib and Nivolumab in Treating Participants With Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid Neoplasm
Ohio State University Comprehensive Cancer Center 16
Early research (Phase 1)Active Not RecruitingNCT04877717
What this trial is testing

SHR-A1904 in Patients With Advanced Solid Cancer

Who this might be right for
Advanced Solid Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 107
Early research (Phase 1)Ended earlyNCT03582280
What this trial is testing

The Effect of Amorphous Calcium Carbonate (ACC) Treatment on Function and Welfare in Late-stage Solid Cancer Subjects

Who this might be right for
Oncology
Amorphical Ltd. 11
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Testing effectiveness (Phase 2)Study completedNCT04645069
What this trial is testing

ADG126, ADG126 in Combination With Anti PD1 Antibody, and ADG126 in Combination With ADG106 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 58
Early research (Phase 1)Not Yet RecruitingNCT05474859
What this trial is testing

Subjects With Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Metastatic Solid TumorAdvanced Solid Tumor
Xenthera, Inc. 30
Early research (Phase 1)Study completedNCT00374179
What this trial is testing

CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Adnexus, A Bristol-Myers Squibb R&D Company 40
Testing effectiveness (Phase 2)Looking for participantsNCT05423262
What this trial is testing

TRK-950 in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorMelanoma
Toray Industries, Inc 49
Early research (Phase 1)Study completedNCT00874042
What this trial is testing

Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 74
Early research (Phase 1)Study completedNCT00732420
What this trial is testing

Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors

Who this might be right for
Solid Tumours
GlaxoSmithKline 68
Not applicableLooking for participantsNCT04243720
What this trial is testing

Immune Resistance Interrogation Study

Who this might be right for
CancerSolid TumorMetastatic Cancer+1 more
University Health Network, Toronto 100
Early research (Phase 1)Study completedNCT00516724
What this trial is testing

Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel

Who this might be right for
Triple Negative Metastatic Breast CancerAdvanced Ovarian CancerCarboplatin+1 more
AstraZeneca 189
Early research (Phase 1)Study completedNCT02323880
What this trial is testing

Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas

Who this might be right for
Malignant GliomaRecurrent Brain NeoplasmRecurrent Childhood Central Nervous System Neoplasm+7 more
Children's Oncology Group 59
Testing effectiveness (Phase 2)Looking for participantsNCT07002203
What this trial is testing

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRecurrent Cancer+2 more
Seqker Biosciences, Inc. 10
Large-scale testing (Phase 3)Looking for participantsNCT03750227
What this trial is testing

Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors

Who this might be right for
Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
Mayo Clinic 140
Not applicableStudy completedNCT00096590
What this trial is testing

Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery

Who this might be right for
ThromboembolismUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT03673020
What this trial is testing

Phase 1a Study to Evaluate Immunogenicity of ASV®

Who this might be right for
Solid Tumor, Adult
Agenus Inc. 3
Testing effectiveness (Phase 2)Study completedNCT00889382
What this trial is testing

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Who this might be right for
Ovarian CancerSolid Tumors
Astellas Pharma Inc 152
Early research (Phase 1)Study completedNCT05735366
What this trial is testing

SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Chugai Pharmaceutical 22
Early research (Phase 1)Study completedNCT00698243
What this trial is testing

Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Any Solid Tumor or Lymphoma
Astellas Pharma Inc 128
Next Page